Novedades

• FDA approves generic teriparatide and levetiracetam
• US generics launch and approval for Dr Reddy’s and Lupin
• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs

Investigación

• Japan’s drug shortage crisis: challenges and policy solutions
• Saudi FDA drug approvals and GMP inspections: trend analysis
• Generic medications in the Lebanese community: understanding and public perception
• Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study

General

• Crecimiento de medicamentos genéricos en Brasil y Venezuela
• EMA launches European shortages monitoring platform to tackle persistent medicine shortages
• Penetración de los medicamentos genéricos en México y Brasil
• FDA releases one-year progress report for the Generic Drug Cluster

Novedades

• EMA recommends approval for three denosumab biosimilars: Bomyntra, Conexxence, and Rolcya
• FDA approves bevacizumab biosimilar Jobevne
• EMA recommends nine biosimilars for approval including trastuzumab and denosumab
• Australia biosimilar approvals in early 2025

Investigación

• Estudios de eficacia clínica en biosimilares: ¿siguen siendo necesarios?
• How the WHO is expanding access to biosimilars
• Optimización de costes con biosimilares: El caso de Brasil
• Biosimilares en países de ingresos bajos y medios

General

• Biosimilars approved in the US
• Biosimilars approved in Australia
• Chinese biosimilars go global: growth, partnerships, and challenges
• Biosimilars approved in Europe

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados